As ENPP1 produces PPi, a potent endogenous inhibitor of hydroxyapatite crystal formation, it has been reported that certain ENPP1-deficient patients develop PXE, a disorder characterized by ectopic mineralization of the matrix in the skin, eyes, and cardiovascular system (5, 26). This evidence concerns the gene ENPP1 and pseudoxanthoma elasticum (inherited or acquired).